Merck
CN

840457C

Avanti

16:0-18:1 PG(磷脂酰甘油)

Avanti Polar Lipids

登录to View Organizational & Contract Pricing

Select a Size

Change View
别名:
1-十六酰基-2-(9Z-十八烯酰基)-sn-甘油基-3-磷酸-(1′rac甘油)(钠盐);POPG;PG(16:0/18:1(9Z));110650
Empirical Formula (Hill Notation):
C40H76O10PNa
分子量:
770.99
NACRES:
NA.25

描述

1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

检测方案

>99% (TLC)

形式

liquid

包装

pkg of 1 × 2.5 mL (840457C-25mg)
pkg of 2 × 20 mL (840457C-1g)
pkg of 2 × 4 mL (840457C-200mg)
pkg of 5 × 4 mL (840457C-500mg)

manufacturer/tradename

Avanti Polar Lipids

浓度

10 mg/mL (840457C-25mg)
25 mg/mL (840457C-1g)
25 mg/mL (840457C-200mg)
25 mg/mL (840457C-500mg)

lipid type

phospholipids

运输

dry ice

储存温度

−20°C

InChI

1S/C40H77O10P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,37-38,41-42H,3-16,19-36H2,1-2H3,(H,45,46);/q;+1/p-1/b18-17-;/t37?,38-;/m1./s1

InChI key

FJXDNGDRHUDFST-XQYKCTAGSA-M

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
840457P840497P840497C
16:0-18:1 PG Avanti Polar Lipids

Avanti

840457P

16:0-18:1 PG

16:0-18:2 PG 1-palmitoyl-2-linoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), powder

Avanti

840497P

16:0-18:2 PG

16:0-18:2 PG 1-palmitoyl-2-linoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

Avanti

840497C

16:0-18:2 PG

form

liquid

form

powder

form

powder

form

liquid

packaging

pkg of 1 × 2.5 mL (840457C-25mg), pkg of 2 × 20 mL (840457C-1g), pkg of 2 × 4 mL (840457C-200mg), pkg of 5 × 4 mL (840457C-500mg)

packaging

pkg of 1 × 1 g (840457P-1g), pkg of 2 × 100 mg (840457P-200mg), pkg of 5 × 100 mg (840457P-500mg), pkg of 1 × 25 mg (840457P-25mg)

packaging

pkg of 1 × 25 mg (840497P-25mg)

packaging

pkg of 1 × 2.5 mL (840497C-25mg)

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids 840497P

manufacturer/tradename

Avanti Polar Lipids 840497C

concentration

10 mg/mL (840457C-25mg), 25 mg/mL (840457C-1g), 25 mg/mL (840457C-200mg), 25 mg/mL (840457C-500mg)

concentration

-

concentration

-

concentration

10 mg/mL (840497C-25mg)

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

一般描述

磷酸甘油酯(PG)也称为甘油磷脂。它是双层膜的重要组成部分。它具有甘油的三碳骨架和两个长链脂肪酸,脂肪酸与甘油的碳1和碳2上的羟基酯化,而磷酸与甘油的C3羟基酯化。它在所有细胞膜中的含量都很高,而在脂肪库(fat store)中含量低。16:0-18:1 PG(磷脂酰甘油)/1-棕榈酰-2-油酰-sn-甘油-3-磷酸-(1′-rac-甘油)(POPG)是带一个负电荷的阴离子脂质。

应用

16:0-18:1 PG(磷脂酰甘油)已用于制备脂质体。适合作为单油酸甘油酯组分,用于处理纯化的β2-肾上腺素受体(β2AR)-T4溶菌酶(T4L)- Gαs α5螺旋(GsCT)-CC嵌合蛋白,并用于制备脂质囊泡。

生化/生理作用

磷酸甘油 (PG)/甘油磷脂在细胞信号传导系统中起关键作用。它也充当细胞膜中蛋白质的锚。

包装

30 mL带螺旋盖的琥珀色窄口玻璃瓶(840457C-1g)
5 mL透明玻璃密封安瓿(840457C-200mg)
5 mL透明玻璃密封安瓿(840457C-25mg)
5 mL透明玻璃密封安瓿(840457C-500mg)

象形图

Skull and crossbonesHealth hazard

警示用语:

Danger

危险分类

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

靶器官

Central nervous system

储存分类代码

6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

危险化学品
易制毒化学品(2类)

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

在网站页面上,产品编号会附带包装尺寸/数量一起显示(例如:T1503-25G)。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题?欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ (Lot或Batch)字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等,请输入去除前两位字母的批号:09019TO。

  • 如果您查询到的批号含有填充代码(例如05427ES-021),请输入去除填充代码-021的批号:05427ES。

  • 如果您查询到的批号含有填充代码(例如 STBB0728K9),请输入去除填充代码K9的批号:STBB0728。

未找到您寻找的产品?

部分情况下,可能未在线提供COA。如果搜索不到COA,可在线索取。

索取COA

其他客户在看

Slide 1 of 8

1 of 8

16:0-18:1 D5 PG 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol-1′,1′,2′,3′,3′-d5) (ammonium salt), powder

Avanti

860385P

16:0-18:1 D5 PG

18:0-18:1 PS 1-stearoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (sodium salt), powder

Avanti

840039P

18:0-18:1 PS

18:0 TAP Avanti Polar Lipids 890880P, powder

Avanti

890880P

18:0 TAP

18:1 (Δ9-Cis) PC (DOPC) Avanti Polar Lipids

Avanti

850375C

18:1 (Δ9-Cis) PC (DOPC)

14:0 PC (DMPC) 1,2-dimyristoyl-sn-glycero-3-phosphocholine, chloroform

Avanti

850345C

14:0 PC (DMPC)

18:1 PS (DOPS) Avanti Polar Lipids

Avanti

840035C

18:1 PS (DOPS)

16:0-18:1 PS (POPS) Avanti Polar Lipids

Avanti

840034C

16:0-18:1 PS (POPS)

16:0 PC (DPPC) Avanti Polar Lipids

Avanti

850355C

16:0 PC (DPPC)

Structural insights into the process of GPCR-G protein complex formation
Liu X, et al.
Cell, 177(5), 1243-1251 (2019)
Ionization Properties of Phospholipids Determined by Zeta Potential Measurements
Sathappa M and Alder NN
Bio-protocol, 6(22) (2016)
Lipids
Medical Biochemistry, 99-119 (2017)
Membrane Structure and Dynamics
Cell Biology, 227-239 (2017)
Mechanism of four de novo designed antimicrobial peptides
Murray B, et al.
Test, 291(49), 25706- 25715 (2016)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门